Submission Details
| 510(k) Number | K221048 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 08, 2022 |
| Decision Date | December 23, 2022 |
| Days to Decision | 259 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K221048 is an FDA 510(k) clearance for the Episealer Patellofemoral System, a Prosthesis, Knee, Patello/femoral, Semi-constrained, Cemented, Metal/polymer (Class II — Special Controls, product code KRR), submitted by Episurf Medical, Inc. (New York, US). The FDA issued a Cleared decision on December 23, 2022, 259 days after receiving the submission on April 8, 2022. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3540.
| 510(k) Number | K221048 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 08, 2022 |
| Decision Date | December 23, 2022 |
| Days to Decision | 259 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | KRR — Prosthesis, Knee, Patello/femoral, Semi-constrained, Cemented, Metal/polymer |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3540 |